US EditionREPORTING. "It Remains Produced in France": Now Half American, the Manufacturer of Doliprane Wants to Reassure on the Production of the Medicine
Summary by franceinfo.fr
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
Since its acquisition by the CD&R investment fund, Opella has been half under the American flag and has opened the doors of its industrial site in Compiègne to the press on Thursday. The aim was to reassure us of the sustainability of Doliprane's production.
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
